These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32047969)

  • 21. Hyaluronic acid improves pain symptoms more than bladder storage symptoms in women with interstitial cystitis.
    Hung MJ; Tsai CP; Lin YH; Huang WC; Chen GD; Shen PS
    Taiwan J Obstet Gynecol; 2019 May; 58(3):417-422. PubMed ID: 31122535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of intravesical instillation with fulguration-hydrodistention on female interstitial cystitis].
    Xin P; Zhang H; Jiang ZM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):865-870. PubMed ID: 37807741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of onabotulinum toxin-A injection on sexual function in women with refractory interstitial cystitis/bladder pain syndrome: A prospective study.
    Karaburun MC; Kubilay E; Öztuna D; Gökçe Mİ; Süer E; Gülpınar Ö
    Low Urin Tract Symptoms; 2024 Mar; 16(2):e12511. PubMed ID: 38527461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Kuo YC; Kuo HC
    Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
    Liang CC; Lin YH; Hsieh WC; Huang L
    Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravesical hyaluronic acid for interstitial cystitis/painful bladder syndrome: a comparative randomized assessment of different regimens.
    Lai MC; Kuo YC; Kuo HC
    Int J Urol; 2013 Feb; 20(2):203-7. PubMed ID: 22925498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated onabotulinumtoxin-a injections provide better results than single injection in treatment of painful bladder syndrome.
    Kuo HC
    Pain Physician; 2013 Jan; 16(1):E15-23. PubMed ID: 23340540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study.
    Giberti C; Gallo F; Cortese P; Schenone M
    Ther Adv Urol; 2013 Aug; 5(4):175-9. PubMed ID: 23904856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in sexual function of women with refractory interstitial cystitis/bladder pain syndrome after intravesical therapy with a hyaluronic acid solution.
    Hung MJ; Su TH; Lin YH; Huang WC; Lin TY; Hsu CS; Chuang FC; Tsai CP; Shen PS; Chen GD
    J Sex Med; 2014 Sep; 11(9):2256-63. PubMed ID: 24636240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis.
    Nickel JC; Egerdie B; Downey J; Singh R; Skehan A; Carr L; Irvine-Bird K
    BJU Int; 2009 Jan; 103(1):56-60. PubMed ID: 18778342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
    Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
    Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndrome.
    Kim A; Lim B; Song M; Choo MS
    Int Neurourol J; 2014 Sep; 18(3):163-7. PubMed ID: 25279245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intravesical cocktail therapy combined with low-dose amitriptyline on primary bladder pain syndrome.
    Abat D; Altunkol A; Gökalp F
    Int Urogynecol J; 2022 May; 33(5):1225-1230. PubMed ID: 34977954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome.
    Chuang YC; Lee WC; Lee WC; Chiang PH
    J Urol; 2009 Oct; 182(4):1393-400. PubMed ID: 19683290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravesical treatment for interstitial cystitis/painful bladder syndrome: a network meta-analysis.
    Zhang W; Deng X; Liu C; Wang X
    Int Urogynecol J; 2017 Apr; 28(4):515-525. PubMed ID: 27614759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and dose flexibility clinical evaluation of intravesical liposome in patients with interstitial cystitis or painful bladder syndrome.
    Lee WC; Chuang YC; Lee WC; Chiang PH
    Kaohsiung J Med Sci; 2011 Oct; 27(10):437-40. PubMed ID: 21943815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Efficacy and Safety of Repeated Intravescial OnabotulinumtoxinA Injections Plus Hydrodistention in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.
    Lee CL; Kuo HC
    Toxins (Basel); 2015 Oct; 7(10):4283-93. PubMed ID: 26506388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety comparison of pharmacotherapies for interstitial cystitis and bladder pain syndrome: a systematic review and Bayesian network meta-analysis.
    Di XP; Luo DY; Jin X; Zhao WY; Li H; Wang KJ
    Int Urogynecol J; 2021 May; 32(5):1129-1141. PubMed ID: 33638677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome.
    Lim YN; Dwyer P; Murray C; Karmakar D; Rosamilia A; Thomas E
    Int Urogynecol J; 2017 Jul; 28(7):1085-1089. PubMed ID: 27987022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral Stents Following Endourological Interventions.
    Raisin G; Dothan D; Perez D; Ala-Adin N; Kafka I; Shenfeld O; Hatumi S; Malchi N; Gordon A; Touitou D; Moldwin R; Nassar T; Chertin B
    Urology; 2023 Aug; 178():42-47. PubMed ID: 37268171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.